rapid
global
emerg
caus
signific
health
concern
highlight
immedi
need
antivir
viral
rnadepend
rna
polymeras
rdrp
play
essenti
role
viral
rna
synthesi
thu
remain
target
choic
prophylact
cur
treatment
sever
viral
diseas
due
high
sequenc
structur
conserv
date
promis
broadspectrum
class
viral
rdrp
inhibitor
nucleosid
analogu
na
approv
treatment
sever
medic
import
viral
diseas
howev
coronavirus
stand
particularli
challeng
case
na
drug
design
due
presenc
exonucleas
exon
domain
capabl
excis
incorpor
na
thu
provid
resist
mani
avail
antivir
use
avail
structur
sarscov
rdrp
exon
protein
well
lassa
viru
n
exonucleas
deriv
model
catalyt
compet
enzym
map
promis
na
candid
activ
metabolit
remdesivir
nucleosid
activ
site
protein
identifi
residu
import
nucleotid
recognit
discrimin
excis
interestingli
address
enzym
activ
site
manner
consist
signific
incorpor
delay
chain
termin
alter
excis
due
ribos
group
may
account
increas
antivir
effect
compar
avail
analogu
addit
propos
structur
function
implic
two
previous
identifi
rdrp
resist
mutat
relat
resist
remdesivir
studi
highlight
import
consid
balanc
incorpor
excis
properti
na
rdrp
exon
recent
emerg
new
sarslik
coronaviru
decemb
name
like
huanan
seafood
market
wuhan
china
caus
signific
global
health
concern
shown
closest
relat
two
batderiv
sarslik
cov
overal
sequenc
ident
sarscov
merscov
present
time
mention
number
case
affect
countri
casefat
ratio
outdat
print
time
coronavirus
cov
envelop
positivesens
rna
virus
order
nidoviral
genom
size
rang
kilobas
potenti
broadspectrum
target
includ
viral
gene
product
wide
conserv
exist
host
cell
structur
function
differ
enough
cellular
homolog
achiev
select
inhibit
rna
virus
rnadepend
rna
polymeras
rdrp
present
optim
target
due
crucial
role
rna
synthesi
lack
host
homolog
high
sequenc
structur
conserv
rdrp
remain
target
choic
treatment
sever
viral
diseas
includ
chronic
liver
diseas
caus
hepat
c
viru
infect
arguabl
promis
broadspectrum
class
viral
rdrp
inhibitor
nucleo
ide
analogu
na
upon
deliveri
host
cell
nucleosidenucleotid
prodrug
metabol
activ
form
compet
endogen
nucleotid
substrat
viral
rdrp
na
subsequ
incorpor
nascent
viral
rna
rdrp
account
antivir
effect
sever
mechan
action
moa
firstli
na
incorpor
may
caus
termin
rna
synthesi
either
oblig
ie
analogu
lack
requir
rna
chain
extens
nonoblig
ie
analogu
perturb
product
rna
structur
enough
stop
synthesi
polymeras
sofosbuvir
prodrug
cmeump
act
chaintermin
nonetheless
combin
drug
sofosbuvir
wide
success
use
cure
hcv
infect
data
avail
regard
activ
coronavirus
second
moa
exist
without
termin
slowdown
rna
synthesi
rather
high
level
incorpor
natp
throughout
nascent
rna
na
unabl
recogn
regular
watsoncrick
nucleobas
subsequ
round
rna
synthesi
nacontain
templat
result
increas
mutat
ultim
lead
nonviabl
genom
process
known
lethal
mutagenesi
ribavirin
rbv
favipiravir
belong
class
antivir
activ
varieti
virus
eg
hcv
influenza
viru
ebola
viru
case
sarscov
rbv
show
efficaci
infect
cell
rbvmp
incorpor
rna
vitro
howev
drug
control
coronaviru
replic
patient
likewis
mutagen
effect
hydroxycytidin
isopropyl
ester
prodrug
number
virus
demonstr
includ
coronavirus
rdrp
domain
fig
one
nonconserv
mutat
subsequ
perform
structurebas
align
use
avail
cryoem
structur
sarscov
evalu
potenti
structur
function
impact
amino
acid
chang
fig
sarscov
rdrp
domain
adopt
classic
right
hand
fold
finger
thumb
palm
subdomain
structur
sequenc
level
conserv
canon
g
motif
readili
identifi
none
mutat
map
within
motif
conclud
rdrp
structur
function
unlik
differ
significantli
sarscov
allow
latter
consid
faith
surrog
structurefunct
analysi
absenc
xray
cryoem
structur
ternari
complex
cov
rdrp
bound
rna
templateprim
incom
nucleotid
triphosph
ntp
took
advantag
structur
phylogenet
related
picornaviru
rdrp
structur
sever
ternari
rdrprnantp
elong
complex
exist
use
sarscov
cryoem
structur
pdb
built
model
stack
onto
set
relat
rdrp
describ
peersen
use
rna
polymeras
ternari
complex
posit
rna
incom
ntp
rna
atp
subsequ
model
sarscov
activ
site
overal
structur
similar
polioviru
polymeras
motif
ag
encircl
constitut
polymeras
activ
site
open
ntp
entri
tunnel
lead
catalyt
center
fig
cov
motif
b
c
f
conserv
conserv
extend
picornavirida
flavivirida
famili
thu
reason
extrapol
mechan
action
similar
viral
rdrp
particular
picornavirida
cov
share
small
thumb
featur
ribos
moieti
ntp
pois
incorpor
properli
posit
conserv
serin
locat
motif
b
probabl
residu
motif
f
fig
light
blue
purpl
see
spectrum
na
activ
human
pathogen
cov
recent
review
five
na
remdesivir
hydroxycytidin
gemcitabin
mizoribin
acyclovirflexim
show
moderatetopot
activ
three
human
pathogen
cov
sarscov
merscov
one
strike
featur
activ
spectrum
structur
peculiar
analogu
rel
potenc
toward
cov
well
rna
virus
obvious
activ
spectrum
link
either
modifi
ribos
modifi
base
remdesivir
one
nucleotid
analogu
report
activ
sarscov
review
carri
cyano
group
posit
ribos
nucleobas
pseudoadenin
link
ribos
cc
bond
fig
figur
show
natur
substrat
atp
pois
receiv
catalyt
nucleophil
attack
model
gs
activ
site
show
group
freeli
accommod
close
vicin
motif
b
fig
motif
report
act
fidel
checkpoint
activ
site
closur
conserv
serin
see
neither
resist
mutat
directli
impact
catalyt
site
substratebind
pocket
rather
caus
minor
structur
alter
like
impact
ntp
check
step
perform
polymeras
catalysi
fig
b
residu
locat
hydrophob
core
protein
interfac
finger
palm
subdomain
fig
phenyl
ring
orient
toward
hydrophob
residu
palm
finger
play
structur
role
tighten
two
domain
strong
mesh
hydrophob
interact
contrast
residu
locat
end
motif
f
second
strand
form
side
rna
templat
entri
channel
fig
base
theoret
model
deriv
polioviru
polymeras
elong
complex
predict
valin
side
chain
face
templat
rna
interact
base
pair
incom
ntp
complet
buri
partial
expos
solvent
solvent
access
respect
nevertheless
server
protein
thermodynam
stabil
chang
upon
singlesit
mutat
predict
mutat
slight
increas
free
energi
protein
correspond
structur
relax
conserv
mutat
reduc
amount
interact
within
hydrophob
core
therebi
retain
overal
conform
lower
structur
rigid
result
increas
free
energi
allow
greater
degre
freedom
secondari
structur
element
harbor
hydrophob
residu
relat
viral
rdrp
serin
motif
b
thought
respons
allow
proper
posit
ribos
moieti
incom
ntp
via
establish
hydrogen
bond
network
oh
group
ribos
fig
structur
motif
b
consid
loos
conform
chang
upon
bind
ntp
consid
fidel
check
point
viral
rdrp
therefor
one
possibl
interpret
phenylalanin
leucin
mutat
allow
relax
posit
serin
lead
alter
fidel
check
detail
experiment
work
use
eg
presteadi
state
kinet
would
determin
better
incorpor
atp
rel
gs
might
achiev
valin
also
locat
vicin
motif
b
fig
c
consequ
valin
leucin
mutat
extend
hydrophob
side
chain
gener
steric
hindranc
templat
rna
result
expect
rna
would
deviat
grove
away
serin
motif
b
possibl
hypothes
deviat
would
alter
serin
fidel
check
allow
easier
incorpor
atp
rel
gs
thu
result
discrimin
latter
valid
hypothesi
requir
detail
kinet
investig
nucleotid
incorpor
activ
site
interest
note
nucleotid
show
possibl
room
hint
gs
incorpor
could
potenti
transloc
fig
overal
ident
sequenc
sarscov
frankfurt
isol
isol
regard
entir
gene
exon
domain
alon
fig
aminoacid
chang
exon
domain
four
involv
nonconserv
aminoacid
exon
activ
site
structur
defin
three
conserv
motif
dxe
w
x
el
daimtr
none
aminoacid
chang
map
motif
confirm
structur
base
align
perform
similar
way
fig
aminoacid
chang
thu
consid
polymorph
sarscov
exon
domain
consid
valid
model
took
advantag
sarscov
crystal
structur
exonucleas
structur
lassa
n
protein
protein
belong
de
de
dh
famili
lassa
n
exon
domain
crystal
dsrna
thu
allow
model
dsrna
exon
activ
site
fig
pseudoadenin
surround
nucleotid
fig
word
pseudoadenin
basepair
properli
would
push
away
unalign
catalysi
metal
ion
thu
like
excis
gs
significantli
less
effici
regular
nucleotid
altern
gs
might
remain
stuck
polymeras
activ
site
describ
delay
chain
termin
inaccess
excis
taken
togeth
structur
featur
gs
consist
latter
act
natp
substrat
activ
site
somehow
disabl
substrat
excis
exon
could
account
anticov
effect
proven
recent
outbreak
emerg
new
signific
human
pathogen
zoonot
cov
threat
develop
broadspectrum
antivir
remain
prioriti
rdrp
domain
remain
extrem
attract
target
antivir
due
high
level
structuralconserv
across
divers
rna
virus
denot
potenti
broadspectrum
applic
coupl
advantag
rel
high
barrier
resist
mutat
na
constitut
attract
option
success
sever
divers
rna
virus
nevertheless
cov
particularli
challeng
case
due
addit
presenc
uniqu
exonucleas
activ
gene
product
confer
resist
sever
commonli
use
na
interestingli
mhv
previous
identifi
potenti
fidelityregul
residu
cov
base
comparison
known
fidelityalt
mutant
coxsacki
polymeras
mutat
engin
murin
hepat
viru
cov
associ
decreas
accumul
mutat
time
aka
increas
fidel
shown
confer
resist
mutagen
conserv
fidelityregul
residu
distantli
relat
rna
virus
indic
rdrp
function
analog
manner
due
high
level
structuralconserv
despit
limit
sequencesimilar
discov
design
novel
potent
na
cov
addit
level
complex
address
rel
rna
pathogen
virus
na
incorpor
coronavir
rna
escap
proofread
exon
brought
nterminu
domain
absenc
structur
data
reason
resolut
drugdesign
ie
complex
relev
substrat
show
relat
lassa
viru
n
protein
exon
domain
type
data
exist
guid
na
moa
studi
shown
figur
highlight
ag
motif
structur
model
made
use
chimera
